80 FR 107 pg. 31909 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP); Initial Review
Type: NOTICEVolume: 80Number: 107Page: 31909
Page: 31909FR document: [FR Doc. 2015-13622 Filed 6-3-15; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Centers for Disease Control and Prevention
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP); Initial Review
In accordance with Section 10(a)(2) of the Federal AdvisoryCommittee Act (Pub. L. 92-463), the Centers for DiseaseControl and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcement, RFA-TS-15-001, Analyze and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS).
Times and Dates: 9:00 a.m.-5:00 p.m., EDT, June 30, 2015 (CLOSED).
Place: The Georgian Terrace, 659 Peachtree Street NE., Atlanta,Georgia 30308. This meeting will also be held by teleconference.
Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.
Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to "Analyze and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)", TS15-001.
Contact Person for More Information: Jane Suen, Dr.P.H., M.S., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F63, Atlanta, Georgia 30341-3724, Telephone (770) 488-4281.
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and DiseaseRegistry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. 2015-13622 Filed 6-3-15; 8:45 am]
BILLING CODE 4163-18-P